Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/1995
08/30/1995EP0668767A1 Antibodies detecting stromelysin cleavage products
08/30/1995EP0555276B1 Immunogenic complexes, in particular iscoms
08/30/1995EP0485577B1 Immunostimulant drug based on polar glycopeptidolipids of mycobacterium chelonae
08/29/1995US5445940 Methods and compositions for detecting and treating a subset of human patients having an autoimmune disease
08/29/1995US5445937 Binding glutamine synthetase(from spinal fluid) to labeled derivatives of adenosine-(or guanosine-)5*-triphosphate, then separation and detection of labeled indicator protein
08/29/1995US5445932 Presence of anti-HDAg'antibodies predicts shortened lifespan of patient
08/29/1995US5445820 Streptolysin O peptide antigens and methods for the determination of streptolysin antibodies
08/29/1995US5445818 Synthetic pseudomonas aeruginosa pilin peptide vaccine and method of use
08/29/1995US5445817 Pertussis toxin used as a carrier protein with non-charged saccharides in conjugate vaccines
08/29/1995CA1336826C Chimeric antibody with specificity to human b cell surface antigen
08/29/1995CA1336818C Treatment of allergy and composition thereof
08/24/1995WO1995022625A1 Dna mutagenesis by random fragmentation and reassembly
08/24/1995WO1995022619A1 B7-1-specific ligands, and their use for the induction of t cell anergy
08/24/1995WO1995022614A1 Production of glycosylphosphatidylinositol-anchored recombinant proteins
08/24/1995WO1995022610A1 Novel integrin alpha subunit
08/24/1995WO1995022607A1 Recombinant equine herpesviruses
08/24/1995WO1995022603A1 Vaccine to control ectoparasites
08/24/1995WO1995022563A1 Antigenic preparation for treatment or prevention of helicobacter infection
08/24/1995WO1995022561A2 Peptides recognized by melanoma-specific cytotoxic lymphocytes, and uses therefor
08/24/1995WO1995022389A1 Antibody purification
08/24/1995WO1995022350A1 Composition and method for preventing and treating inflammation with immunoglobulin a
08/24/1995WO1995022340A1 Methods for altering fertility
08/24/1995WO1995022318A1 Drugs, vaccines and hormones in polylactide coated microspheres
08/24/1995WO1995022317A1 Compositions and methods for eliciting ctl immunity
08/24/1995WO1995019435A3 T cell antigen receptor v region proteins and methods of preparation thereof
08/24/1995DE19505287A1 Zusammensetzung und Verfahren zur Prävention und Behandlung von Entzündungen mit Immunglobulin A A composition and method for the prevention and treatment of inflammation with immunoglobulin A
08/24/1995CA2183680A1 B7-1-specific ligands, and their use for the induction of t cell anergy
08/24/1995CA2183566A1 Composition and method for preventing and treating inflammation with immunoglobulin a
08/24/1995CA2183416A1 Compositions and methods for eliciting ctl immunity
08/24/1995CA2182880A1 Recombinant equine herpesviruses
08/23/1995EP0668356A2 Recombinant infectious bovine rhinotracheitis virus mutant, methods for the production of same, and vaccines containing the same
08/23/1995EP0668350A1 Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma
08/23/1995EP0668077A1 Compositions containing G-CSF and TNF binding protein
08/23/1995EP0667917A1 Evolutive vaccination.
08/23/1995EP0667908A1 Soluble t-cell receptor alpha chain and derivatives used as prophylactic and therapeutic agents for autoimmune diseases
08/23/1995EP0667902A1 Cdr grafted humanised chimeric t-cell antibodies
08/23/1995EP0667901A1 Novel cytokine
08/23/1995EP0667898A1 Tau/neurofilament protein kinases pk40 and pk36
08/23/1995EP0667859A1 Molecule labelling using 2-hydraninopyridine derivatives
08/23/1995EP0667792A1 Specific tolerance in transplantation
08/23/1995EP0667789A1 Restoration of immunocompetency to t helper cells in hiv infected patients
08/23/1995EP0667788A1 Allergenic extracts
08/23/1995EP0667787A1 Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
08/23/1995EP0667786A1 Retro-, inverso-, and retro-inverso synthetic peptide analogues
08/23/1995EP0522010B1 Bcrf1 antagonists for treating epstein-barr virus infections
08/23/1995EP0500576B1 Outer membrane protein p1 and peptides of haemophilus influenzae type b
08/23/1995EP0477240B1 Method of preparing vaccines against rna viruses
08/23/1995EP0371036B1 Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
08/22/1995US5444159 Purification of a pertussis outer membrane protein
08/22/1995US5444158 Merosin, nucleic acids encoding, fragments and uses thereof
08/22/1995US5444153 Plasminogen activator inhibitor which has been altered to eliminate a protease sensitive site
08/22/1995US5444044 Synthetic polypeptides as inhibitors of HIV-1
08/22/1995US5444041 Convertible microemulsion formulations
08/22/1995US5443982 Continuous avian hepatocellular carcinoma cell line containing infectious laryngotracheitis virus
08/22/1995US5443976 Making antivenoms of rattlesnakes by attaching two whole venoms having antibody binding capacity to insoluble aldehyde activated agarose substrate by covelentyl bonding
08/22/1995US5443967 DNA encoding the cancer associated SCM recognition factor
08/22/1995US5443966 Expression of tetanus toxin fragment C
08/22/1995US5443965 Peptide antigens used in diagnosis
08/22/1995US5443955 Receptor membranes and ionophore gating
08/22/1995US5443953 Genetic engineering; diagnosis, therapy
08/22/1995US5443832 Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response
08/22/1995US5443831 A polynucleotide immunogens protecting chicken against viral disease
08/22/1995US5443829 For enhancing delivery of drugs across mucous membranes of animals
08/22/1995US5443828 AIDS vaccine
08/22/1995US5443827 Chimeric molecule; anticoagulants
08/22/1995CA1336763C Monoclonal antibodies capable of recognizing n-acetylneuraminic acid in beta-arrangement
08/22/1995CA1336760C Antibody-mediated and ligand-mediated targeting of differentiation-inducers to tumor cells
08/17/1995WO1995021928A1 Process for the production of a heterologous protein from a methylotrophic yeast
08/17/1995WO1995021926A1 Inducing tolerance with tolerogenic fusion proteins
08/17/1995WO1995021922A2 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
08/17/1995WO1995021921A1 Mammalian thymokine genes
08/17/1995WO1995021915A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/17/1995WO1995021912A1 Non-pathogenic strains of hiv-1
08/17/1995WO1995021868A1 Monoclonal antibodies specific to vegf receptors and uses thereof
08/17/1995WO1995021866A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain
08/17/1995WO1995021865A1 Immunointeractive molecules-i
08/17/1995WO1995021864A1 Antibodies which bind the g-csf receptor extracellular domain and methods of treatment
08/17/1995WO1995021858A2 Mosaic polypeptide and methods for detecting the hepatitis e virus
08/17/1995WO1995021673A1 Preparation and application of artificial anti-idiotypic imprints
08/17/1995WO1995021630A1 Methods for identifying individuals suffering from a cellular abnormality
08/17/1995WO1995021627A1 Active immunization using a siderophore receptor protein
08/17/1995WO1995021625A1 Prolactin as a vaccine adjuvant
08/17/1995WO1995021623A1 Peptides and methods against diabetes
08/17/1995WO1995021622A1 Gel-forming polypeptide derivatives
08/17/1995WO1995021613A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
08/17/1995WO1995021528A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
08/17/1995CA2185683A1 Monoclonal antibodies specific to vegf receptors and uses thereof
08/17/1995CA2183362A1 Mosaic polypeptide and methods for detecting the hepatitis e virus
08/17/1995CA2183260A1 Prolactin as a vaccine adjuvant
08/17/1995CA2183154A1 Non-pathogenic strains of hiv-1
08/17/1995CA2183066A1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells
08/17/1995CA2182978A1 Peptides and methods against diabetes
08/17/1995CA2182977A1 Inducing tolerance with tolerogenic fusion proteins
08/17/1995CA2182969A1 Methods for identifying individuals suffering from a cellular abnormality
08/17/1995CA2182682A1 Immunointeractive molecules-i
08/17/1995CA2182681A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain
08/17/1995CA2182574A1 Mammalian thymokine genes
08/17/1995CA2182494A1 Antibodies which bind the g-csf receptor extracellular domain and methods of treatment
08/17/1995CA2166313A1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
08/16/1995EP0667165A1 Therapeutic compositions containing monoclonal antibodies specific to human epidermal growth factor receptor
1 ... 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 ... 1823